characteristics.text: SAMN33717241
characteristics.characteristic: External Id
characteristics.text: dbGaP
characteristics.characteristic: INSDC center name
characteristics.text: 2023-03-11T02:41:06.420Z
characteristics.characteristic: INSDC first public
characteristics.text: 2023-03-31T02:38:07.023Z
characteristics.characteristic: INSDC last update
characteristics.text: SRS17106386
characteristics.characteristic: INSDC secondary accession
characteristics.text: live
characteristics.characteristic: INSDC status
characteristics.text: Generic
characteristics.characteristic: NCBI submission model
characteristics.text: Generic.1.0
characteristics.characteristic: NCBI submission package
characteristics.text: SRS17106386
characteristics.characteristic: SRA accession
characteristics.text: RNA
characteristics.characteristic: analyte type
characteristics.text: NCI_LCCC1525_mTNBC
characteristics.characteristic: biospecimen repository
characteristics.text: 121_Tumor_RNASeq_Pre
characteristics.characteristic: biospecimen repository sample id
characteristics.text: LYMPH_NODE
characteristics.characteristic: body site
characteristics.text: phs002659
characteristics.characteristic: gap_accession
characteristics.text: 1
characteristics.characteristic: gap_consent_code
characteristics.text: DS-BRCA-IRB
characteristics.characteristic: gap_consent_short_name
characteristics.text: 5341159
characteristics.characteristic: gap_sample_id
characteristics.text: 4419186
characteristics.characteristic: gap_subject_id
characteristics.text: Yes
characteristics.characteristic: is tumor
characteristics.text: Homo sapiens
characteristics.ontologyTerms: http://purl.obolibrary.org/obo/NCBITaxon_9606
characteristics.characteristic: organism
characteristics.text: female
characteristics.characteristic: sex
characteristics.text: Interventional
characteristics.characteristic: study design
characteristics.text: Triple Negative Breast Neoplasms
characteristics.characteristic: study disease
characteristics.text: Genomics from LCCC1525: A Priming Dose of Cyclophosphamide Prior to Pembrolizumab to Treat mTNBC
characteristics.characteristic: study name
characteristics.text: Yes
characteristics.characteristic: subject is affected
characteristics.text: 121_Tumor_RNASeq_Pre
characteristics.characteristic: submitted sample id
characteristics.text: 121
characteristics.characteristic: submitted subject id
characteristics.text: NCI_LCCC1525_mTNBC
characteristics.characteristic: submitter handle
characteristics.text: Triple Negative Breast Neoplasms tumor RNA sample from LYMPH_NODE of a human female participant in the dbGaP study Genomics from LCCC1525: A Priming Dose of Cyclophosphamide Prior to Pembrolizumab to Treat mTNBC
characteristics.characteristic: title